#India #Mumbai #Women's Health #Natural Ingredients #Fenavari

OmniActive Health Technologies Unveils Fenavari

In a significant step forward for women’s health, OmniActive Health Technologies has announced the launch of Fenavari, a proprietary botanical ingredient specifically designed to support women experiencing hormonal changes during perimenopause, menopause, and post-menopause. This innovation is backed by clinical research, offering a first-of-its-kind scientific validation that sets it apart in the wellness marketplace.

The Unique Blend of Botanicals

Fenavari combines two powerful botanicals: fenugreek (Trigonella foenum-graecum) and shatavari (Asparagus racemosus). This integrated extract employs a multi-benefit approach to address various symptoms associated with midlife hormonal fluctuations. Recent studies published in Women's Health Reports have substantiated Fenavari's efficacy in managing a range of issues, from hot flashes and night sweats to maintaining sleep quality, mood balance, and overall sexual wellness.

A Growing Concern for Women

Understanding the rising visibility of menopause as a critical stage in women's health, OmniActive conducted proprietary research involving nearly 500 women over 45. The findings revealed that a staggering 61% reported experiencing hot flashes, while 62% faced difficulties sleeping. Furthermore, 51% of these women experienced mood swings, with the majority turning to natural remedies and over-the-counter options for relief.

Keya Shah, Senior Director of the Women’s Health Category at OmniActive, noted, "While shatavari is gaining in popularity, both it and fenugreek have a rich historical background in supporting women’s health. Fenavari synthesizes the strengths of these botanicals into a clinically studied extract that provides a holistic solution for women navigating the menopausal journey. In a recent survey, an impressive 90% of healthcare professionals indicated they would recommend Fenavari to their patients for managing menopause-related symptoms."

Clinical Validation of Fenavari

The efficacy of Fenavari was demonstrated in a randomized, double-blind, placebo-controlled clinical trial involving 138 women aged between 40 and 60. Participants taking either 300 mg or 500 mg doses reported significant improvements in their menopausal symptoms as early as 14 days into the supplementation. The results included:

• - A 52% reduction in hot flashes at 300 mg and 61% at 500 mg.
• - A 47% reduction in night sweats at 300 mg and 51% at 500 mg.
• - Positive impacts on sleep quality, mood, and occasional feelings of anxiety.
• - Improvement in sexual wellness and maintenance of healthy hormonal balance, with increased estradiol and decreased follicle-stimulating hormone (FSH) levels.

Fenavari’s potency lies in its distinct phytochemical profiles derived from fenugreek and shatavari, extracted using proprietary technology that standardizes the active components to 6% shatavarin IV and 4% protodioscin. This advanced extraction ensures that the complementary phytoestrogenic and adaptogenic properties of both botanicals are preserved, providing a more comprehensive wellness solution for women entering midlife.

A Commitment to Women’s Health

The launch of Fenavari fills an important gap in the marketplace by offering a clinically validated, integrated botanical solution. As menopause-related wellness needs gain attention, Fenavari aims to simplify the formulation process for brands while delivering effective results for consumers. It will be produced using eco-friendly methods, ensuring it is free from hormones, estrogen, and soy.

As OmniActive continues to innovate, they are also committed to expanding clinical research further to solidify Fenavari’s standing in the natural health sector. The product is expected to be available to formulators later this year, broadening options for women's health products in an evolving market. For more information, visit OmniActive's website.

About OmniActive Health Technologies

Founded in 2005, OmniActive Health Technologies stands at the forefront of consumer wellness with a strong commitment to improving quality through innovative science and natural ingredients. With a broad portfolio of specialty actives for dietary supplements and functional foods, the company specializes in providing evidence-based solutions to meet global customer needs. Offices are strategically located in Mumbai, India, Bridgewater, New Jersey, and Amsterdam, Netherlands.